Drug Shortage Report for POTASSIUM PHOSPHATES INJECTION, USP
| Report ID | 11547 |
| Drug Identification Number | 02139545 |
| Brand name | POTASSIUM PHOSPHATES INJECTION, USP |
| Common or Proper name | POTASSIUM PHOSPHATES INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | POTASSIUM PHOSPHATE DIBASIC POTASSIUM PHOSPHATE MONOBASIC |
| Strength(s) | 236MG 224MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 15 |
| ATC code | B05XA |
| ATC description | I.V. SOLUTION ADDITIVES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-08-31 |
| Actual start date | |
| Estimated end date | 2024-12-02 |
| Actual end date | 2024-12-02 |
| Shortage status | Resolved |
| Updated date | 2024-12-03 |
| Company comments | Fresenius Kabi Canada regrets to advise that due to production delays, we will be encountering a supply interruption on our Potassium Phosphates Injection, USP 3 mmol/mL Phosphorus SD Vial 15 mL effective August 31, 2024, until December 2, 2024. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2024-12-03 | English | Compare |
| v8 | 2024-12-02 | French | Compare |
| v7 | 2024-12-02 | English | Compare |
| v6 | 2024-10-22 | French | Compare |
| v5 | 2024-10-22 | English | Compare |
| v4 | 2024-09-01 | English | Compare |
| v3 | 2024-08-08 | French | Compare |
| v2 | 2024-08-08 | English | Compare |
| v1 | 2017-05-30 | English | Compare |
Showing 1 to 9 of 9